About NTx

Meet the team and learn about our mission.

Our Mission

To give therapy-resistant cancer patients an effective treatment option.

Experts in radiotheranostics

Based in the United Kingdom with global expertise, NuclideTx brings together science, technology, and translational leadership to advance the next generation of precision radiopharmaceuticals, turning molecular insight into powerful, life-changing therapies.

Team photo

Experts in radiotheranostics

Based in the United Kingdom with global expertise, NuclideTx brings together science, technology, and translational leadership to advance the next generation of precision radiopharmaceuticals, turning molecular insight into powerful, life-changing therapies.

Team photo

Our team

Experienced professionals dedicated to radiopharmaceutical innovation.

Co Founder & CEO

Muhammet Tanç, PhD

Co Founder & CSO

Tim Witney, PhD

Co Founder & COO

Sofia Santos, PhD

Co Founder & CTO

Richard Edwards, PhD

CFO

Matthias Untisz

Advisory Board Member

Andreas Kluge, MD PhD

Advisory Board Member

Leigh Brody, PhD

Our investors

Grant funding

Strategic partners

Strategic partners

Connect with us

Email us, and keep updated on our clinical trial pipeline on LinkedIn.

Email us

Connect with us

Email us, and keep updated on our clinical trial pipeline on LinkedIn.

Email us

Multi colour gradient with abstract wave form

© 2026 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Designed & Built by Keetley Studio

Multi colour gradient with abstract wave form

© 2026 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Designed & Built by Keetley Studio

Multi colour gradient with abstract wave form

© 2026 Nuclide Therapeutics, All rights reserved

contact@nuclidetx.com

Designed & Built by Keetley Studio